GLRE News 31.52 Greenlight Capital Re (GLRE)

New Post Public Reply Private Reply Replies (0) Message Board

Apr 18, 2014 at 1:20 AM

Greenlight Capital Re (GLRE) 31.52 $GLRE

Global Indemnity (GBLI) Surges: Why It Still Has Room to Run? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 10, 7:39AM CDT
Global Indemnity has been witnessing a significant price rise in the past month with a positive momentum in the earnings estimate front

Greenlight Capital Re Earnings Hindsight: Down 1.4% in Last 20 Days (GLRE)
Comtex SmarTrend(R) - Mon Mar 10, 7:37AM CDT
Two weeks ago on February 18th, 2014 Greenlight Capital Re (NASDAQ:GLRE) reported earnings and analysts, on average, expected earnings of $2.42 on sales of $221.0 million. Greenlight Capital Re actually reported earnings of $2.22 per share on sales of $224.0 million, missing EPS estimates by $0.20 and beating revenue estimates by $3.0 million. Shares of Greenlight Capital Re have slipped from $32.37 to $31.93, representing a loss of 1.4%, since the company reported earnings 20 days ago.

Infinity Property and Casualty Earnings Miss Ests, Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 28, 11:40AM CST
Infinity Property and Casualty reported fourth-quarter 2013 operating earnings of 70 cents a share, missing the Zacks Consensus Estimate of 75 cents by 6.7%.

Global Indemnity (GBLI) in Focus: Stock Moves 8.1% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 24, 8:21AM CST
Global Indemnity plc (GBLI) was a big mover last session, as the company saw its shares rise by over 8% on the day.

RenaissanceRe Hikes Quarterly Dividend - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 21, 3:00PM CST
The board of directors of RenaissanceRe approved a 3.6% increase in its quarterly cash dividend and the company will now pay a dividend of 29 cents per share.

EMC Insurance Beats on Q4 Earnings, Revs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 21, 11:50AM CST
EMC Insurance reported fourth-quarter operating net earnings of 95 cents a share, surpassing the Zacks Consensus Estimate of 87 cents a share by 9.2%

Maiden Beats on Q4 Earnings, Misses Revs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 20, 12:00PM CST
Maiden Holdings reported record fourth-quarter 2013 operating net earnings of 30 cents a share, beating the Zacks Consensus Estimate of 28 cents by 7.1%.

Greenlight Misses on Q4 Earnings, Grows Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 20, 10:00AM CST
Greenlight Capital Re, Ltd. reported fourth-quarter 2013 net earnings per share of $2.22

Greenlight Re Announces Fourth Quarter and Year End 2013 Financial Results
GlobeNewswire - Tue Feb 18, 3:01PM CST
Greenlight Capital Re, Ltd. (Nasdaq:GLRE) today announced financial results for the fourth quarter and year ended December 31, 2013. Greenlight Re reported net income of $83.9 million for the fourth quarter 2013 compared to net loss of $60.6 million for the same period in 2012. Fully diluted net income per share was $2.22 compared to net loss per share of $1.65 for the same period in 2012.

Cincinnati Financial Slips to Neutral - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 11, 5:55PM CST
We are downgrading our recommendation on Cincinnati Financial to Neutral from Outperform, reflecting our concern regarding potential first-quarter earnings drain due to weather-related losses.

Greenlight Capital Re to Release Fourth Quarter and Year End 2013 Results
GlobeNewswire - Tue Feb 11, 3:01PM CST
Greenlight Capital Re, Ltd. (Nasdaq:GLRE), a specialist property and casualty reinsurer based in the Cayman Islands and Ireland, today announced that it expects to release financial results for the fourth quarter and year ended December 31, 2013 after the market closes on Tuesday, February 18, 2014. A live conference call to discuss the financial results will be held on Wednesday, February 19, 2014 at 9:00 a.m. Eastern time.

Markel's Earnings Miss, Revs Top Ests - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 11, 10:20AM CST
Markel reported fourth-quarter 2013 operating net income of $5.92 per share, missing the Zacks Consensus Estimate of $5.99 per share by 1.2%

Q4 Earnings at Allied World Miss Ests, Surge Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 10, 10:40AM CST
Allied World reported fourth-quarter 2013 operating net income of $2.17 per share, missing the Zacks Consensus Estimate of $2.40 by 10.4%

Shares of GLRE Up 37.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Jan 23, 4:56PM CST
SmarTrend identified an Uptrend for Greenlight Capital Re (NASDAQ:GLRE) on January 31st, 2013 at $23.96. In approximately 12 months, Greenlight Capital Re has returned 37.85% as of today's recent price of $33.03.

Greenlight Capital Re Has Returned 40.2% Since SmarTrend Recommendation (GLRE)
Comtex SmarTrend(R) - Thu Jan 16, 11:08AM CST
SmarTrend identified an Uptrend for Greenlight Capital Re (NASDAQ:GLRE) on January 31st, 2013 at $23.96. In approximately 12 months, Greenlight Capital Re has returned 40.23% as of today's recent price of $33.60.

Insurance Industry Stock Outlook - Jan 2014 - Industry Outlook
Kalyan Nandy - Zacks Investment Research - Tue Jan 14, 4:06AM CST
Insurance Industry Stock Outlook - Jan 2014 - Industry Outlook

Insurance Industry Stock Outlook - Jan 2014 - Zacks Analyst Interviews
Kalyan Nandy - Zacks Investment Research - Tue Jan 14, 4:06AM CST
Insurance Industry Stock Outlook - Jan 2014 - Zacks Analyst Interviews

Greenlight Capital (GLRE): Strong Industry, Solid Earnings Estimate Revisions - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jan 13, 7:34AM CST
Greenlight Capital belongs to the Property and Casualty Insurance industry space witnessed solid earnings estimate revision activity and is in great company from a Zacks Industry Rank perspective.

Greenlight Capital Re Shares Up 39.9% Since SmarTrend's Buy Recommendation (GLRE)
Comtex SmarTrend(R) - Thu Jan 09, 9:47AM CST
SmarTrend identified an Uptrend for Greenlight Capital Re (NASDAQ:GLRE) on January 31st, 2013 at $23.96. In approximately 11 months, Greenlight Capital Re has returned 39.86% as of today's recent price of $33.51.

Greenlight Capital Re Up 39.9% Since SmarTrend Uptrend Call (GLRE)
Comtex SmarTrend(R) - Thu Jan 02, 9:17AM CST
SmarTrend identified an Uptrend for Greenlight Capital Re (NASDAQ:GLRE) on January 31st, 2013 at $23.96. In approximately 11 months, Greenlight Capital Re has returned 39.86% as of today's recent price of $33.51.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Love Business Group Helps SMEs Navigate Broadband Choices

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

CapCut's Role in AI-Assisted Small Biz Marketing

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

RYBREVANT's Promising Results in HNSCC Treatment

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Fluence Energy Hits Legal Snag: Investors Called to Act

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Sinclair Faces Labor Lawsuit for Break-time Violations

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Community in Shock After Fatal Bakersfield Shooting

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...